Innovatrics has introduced a new version of its biometric liveness detection technology to ease regulatory compliance and avoid user drop-offs. The global market for face biometric liveness checks is ...

Innovatrics has announced a new liveness detection technology called MagnifEye, which it claims can double the accuracy of liveness detection since the method evaluates multiple biometric inputs.

Sensyne's technology, called MagnifEye, is embedded into the app and can read Excalibur's lateral flow test result through a smartphone camera. MagnifEye is already being used as part of the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Joseph Jacobs had an idea he thought could both work as a ...

Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced ...

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health announced on Friday that its 'MagnifEye' software application, which uses AI to automate the accurate reading and ...

Sensyne Health's MagnifEye AI software product gains MHRA 'Authorisation of Special Use' in connection with DHSC COVID-19 Self-Test Lateral Flow Device The authorisation is specifically for the use of ...

NEW YORK ─ Oxford, UK-based Sensyne Health on Friday said it has inked a £470,000 ($652,500) agreement with the UK Department of Health & Social Care to conduct the second stage of a pilot study that ...

Since 1998, this community has helped people find opportunities, build careers, and connect across the industry. As we close this chapter, we do so with gratitude and pride in what we created together ...

Sensyne Health launches MagnifEye smartphone application to automate the reading and Big Data analysis of lateral flow tests using deep learning AI MagnifEye™ uses a cloud-based deep learning ...